NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 7.96% |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn | 22.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.35% |
| Mar 31, 2026 | 27.90% |
| Dec 31, 2025 | 33.42% |
| Sep 30, 2025 | 39.05% |
| Jun 30, 2025 | 44.62% |
| Mar 31, 2025 | 46.97% |
| Dec 31, 2024 | 50.70% |
| Sep 30, 2024 | 84.31% |
| Jun 30, 2024 | 77.65% |
| Mar 31, 2024 | 71.24% |
| Dec 31, 2023 | 65.31% |
| Sep 30, 2023 | 64.31% |
| Jun 30, 2023 | 57.52% |
| Mar 31, 2023 | 55.06% |
| Dec 31, 2022 | 51.80% |
| Sep 30, 2022 | 52.27% |
| Jun 30, 2022 | 18.74% |
| Mar 31, 2022 | 16.92% |
| Dec 31, 2021 | 13.88% |
| Sep 30, 2021 | -9.65% |